Search research articles

Search research articles

Related Experiment Videos

The allergen specific B-cell response during immunotherapy.

S H Sparholt¹, O T Olsen, C Schou

¹ALK Research, Hørsholm, Denmark.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology

|June 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: Gastric bipartition, a novel metabolic surgery procedure: A retrospective cohort study.

International journal of surgery (London, England)·2016

Same author

A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2004

Same author

Cost-effectiveness of wound management protocols debated.

British journal of nursing (Mark Allen Publishing)·2002

Same author

Standardization of food allergen extracts for skin prick test.

Journal of chromatography. B, Biomedical sciences and applications·2001

Same author

Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample.

European journal of human genetics : EJHG·2001

Same author

Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: comparison with m-iodobenzylguanidine.

Biochemical pharmacology·2000

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

House dust mite immunotherapy boosts specific IgM and IgA antibody-secreting cells, indicating a significant B-cell response. This suggests immunotherapy may induce protective IgA antibody responses in patients.

Area of Science:

Immunology
Allergy Research
B-cell Response

Background:

House dust mite immunotherapy is a treatment for allergic diseases.
Understanding the specific B-cell response during immunotherapy is crucial for optimizing treatment strategies.
Previous studies have not fully elucidated the dynamics of antibody-secreting cells (AbSC) post-immunotherapy.

Purpose of the Study:

To investigate the allergen-specific B-cell response in patients undergoing house dust mite immunotherapy.
To analyze the changes in IgM, IgG, IgA, and IgE antibody-secreting cells (AbSC) in response to Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts.
To compare the B-cell response between actively treated patients and a placebo group.

Main Methods:

A double-blind, placebo-controlled study involving 12 patients receiving house dust mite extract or placebo.

Related Experiment Videos

Blood samples collected bi-weekly and tested for specific IgM, IgG, IgA, and IgE antibody-secreting cells (AbSC) against D. pteronyssinus and D. farinae allergens.

Quantification of total immunoglobulin secreting cells (IgSC) and mononuclear cells (MNC) for normalization.

Main Results:

A significant increase in specific IgM and IgA AbSC was observed following immunotherapy.
No significant change in specific IgG AbSC or IgE AbSC was detected post-treatment.
The B-cell response showed no measurable species specificity between D. pteronyssinus and D. farinae immunotherapy.

Conclusions:

House dust mite immunotherapy induces a significant increase in specific IgM and IgA antibody-secreting cells.
The findings suggest that immunotherapy may promote the induction of allergen-specific IgA AbSC, potentially contributing to mucosal immunity.
Further research is warranted to explore the role of IgA AbSC in the protective mechanisms of inhalant allergen immunotherapy.